The explosion of the direct-to-consumer DNA testing market could be transformative if genomics data is used in conjunction with the NHS to improve our understanding of rare diseases
Incredibly uncommon and hard to diagnose and treat, how can we advance the treatment of ultra-rare diseases if there are still so many unknowns?
Babies are tested for a number of conditions soon after birth, but varied approaches to screening worldwide highlight how fragmented the medical profession remains over this vital process
‘If we embrace our genomic future, we stand to transform the prospects for diagnosis and treatment of rare and common diseases alike’
Genetics and medical studies have largely over-represented people of white, European descent, which could have huge ramifications for the advancement of health research
New technologies, such as the cloud and artificial intelligence, have transformed pharmaceutical supply chains from materials supplier to manufacturer, wholesaler to pharmacy and on to patients
Gene-edited food has the potential to feed the world’s hungry, but may be blocked in the European Union
Healthcare companies are developing technology which utilises the power of artificial intelligence to analyse genomic data and provide personalised treatment for cancer patients